n (%) | |
---|---|
Sex | |
male | 65 (80,2%) |
female | 16 (19,8%) |
Chemotherapy | |
no | 23 (28,4%) |
yes | 58 (71,6%) |
Entity (total radiation dose) | |
SCLC (60 Gy) | 11 (13,6%) |
Esophageal CA (66 Gy) | 35 (43,2%) |
NSCLC (74 Gy) | 35 (43,2%) |
Smoking history | |
never | 6 (7,4%) |
present | 39 (48,1%) |
former | 34 (42,0%) |
unknown | 2 (2,5%) |
T | |
1 | 3 (3,7%) |
2 | 9 (11,1%) |
3 | 48 (59,3%) |
4 | 21 (25,9%) |
N | |
0 | 3 (3,7%) |
1 | 32 (39,5%) |
2 | 15 (18,5%) |
3 | 31 (38,3%) |
M | |
0 | 63 (77,8%) |
1 | 18 (22,2%) |
Treatment technique | |
IMRT | 43 (53,1%) |
VMAT (rapid arc) | 38 (46,9%) |
Total | 81 (100,0%) |